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The hymenolepiosis by Hymenolepis nana is a major public health problem in developing countries, and 
the commercial drugs against this parasitosis are not enough effective. The combination of antiparasitic 
and antioxidant agents has improved the treatment of some parasitoses. Thus, the development of new 
cestocidal and antioxidant agents to treat the hymenolepiosis cases is important. In the present study, 
four hydroxy- and four dihydroxy-chalcones were synthesized using the catalyst boron trifluoride diethyl 
etherate (BF3•OEt2). The antioxidant activity and antiparasitic against H. nana of chalcones were tested, 
as well as the toxicity by the brine shrimp lethality bioassay and the method of Lorke. The antioxidant 
activity was measured by three radical scavenging assays: 2,2’-azino-bis-3-ethylbenzothiazoline-6-
sulphonic acid (ABTS), 2,2-diphenyl-1-picrylhydrazyl (DPPH), and ferric reducing antioxidant power 
(FRAP). The hydroxyl substitution pattern (number and position), mainly in ring B, was responsible for 
the chalcone antiparasitic activity. At least one meta or para hydroxyl group in ring B was essential for 
activity of the synthetic chalcones against H. nana; The time taken for the parasite to die by the 3b and 
3e chalcones (20 mg/mL) treatment was up to six times lower than the control drug Praziquantel. On 
the other hand, chalcones with catechol structure in ring B (3g and 3h) showed the highest antioxidant 
values. The toxicity evaluations suggests that synthetic hydroxychalcones with cestocidal (3b and 3e) and 
antioxidant (3g and 3h) activities are safe compounds and potential in vivo agents to treat this parasitosis.
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INTRODUCTION
Intestinal parasitoses are one of the most important 
public health concerns, around one fifth of the world 
population is infected with at least one parasite (Puente et 
al., 2011). Hymenolepiosis by H. nana is mainly common 
in children, but H. diminuta infections have been also 
reported (Kim et al., 2014). Hymenolepiosis are usually 
asymptomatic, however, heavy infections with more than 
2000 worms can induce a wide range of gastrointestinal 
symptoms, such as abdominal pain and diarrhea (Rim et 
al., 1978). High H. nana prevalences have been registered 
in Africa (17.5%) (Nwele et al., 2013), Asia (0.81%) 
(Shrestha, Maharjan, 2013), Europe (2.1%) (Calik, 
Karaman, Colak, 2011), and in the Americas (11.3-23%) 
(Jacobsen et al., 2007; Quihui et al., 2006). Praziquantel 
is the drug of choice against the hymenolepiosis but 
is not available at public health institutions of many 
underdeveloped countries (King-Charles, Mahmoud-Adel, 
1989; Yadav, 2012) and the development of drug resistant 
parasites has complicated this situation (Chai, 2013), 
therefore the introduction of new cestocidal treatments 
is important. 
Some parasites induce oxidative stress in the infected 
host (Gabrashanska et al., 2010; Niwa, Miyazato, 1996). 
For example, in murine hymenolepiosis, the host produces 
oxygen radicals and shows an impaired antioxidant state 
(Kosik-Bogacka et al., 2011; Niwa, Miyazato, 1996). 
Consequently, combining antiparasitary agents with 
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feeding antioxidants can result in better efficiency in 
the treatment of parasitosis, as demonstrated in murine 
infections with Trichinella spiralis (Gabrashanska et al., 
2010) and Leishmania amazonensis (Gasparotto et al., 
2015).
Chalcones have shown a range of biological 
activities such as anti-inflammatory (Yadav et al., 2011), 
anticancer (Syam et al., 2012), antifungal (Konduru et 
al., 2013), antibacterial (Tran et al., 2012), antioxidant 
(Kim et al., 2008), and antiparasitary (Sissouma et al., 
2011). Hence, organic chemists are interested in the 
synthesis of chalcones with improved biological activities. 
Anthelminthic activity has been associated with the 
substituent group patterns of the aromatic rings in the 
chalcone’s structure (Go et al., 2004), and chalcones 
with one hydroxyl group in ring A have demonstrated an 
increased activity (Laliberté et al., 1968).
Chalcones also show good antioxidant activities 
that are associated with their structures, they have an α,β-
unsaturated functional group as well as aromatic rings 
with variations in the number and position of hydroxyl 
substituent groups (Lakshmi, Rama-Rao, Basaveswararao, 
2014; Todorova et al., 2011). In particular, chalcone 
antioxidant activity has been correlated with its ability to 
transfer hydrogen atoms (Sivakumar, Prabhakar, Doble 
et al., 2011).
The aim of this research was the synthesis of leading 
chalcones with differences in the hydroxylation pattern in 
both rings, and in their antiparasitary activity against H. 
nana, as well as their antioxidant properties.
MATERIAL AND METHODS 
Experimental
The highest quality available reagents were 
purchased and used without further purification. The 
solvents used in column chromatography were obtained 
from commercial suppliers and used without distillation. 
Melting points were determined on a Stuart apparatus 
model SMP30; the reported value is the average of three 
separate experiments. Infrared spectra were recorded on 
a Cary 660 series FTIR-ATR spectrophotometer. Nuclear 
magnetic resonance spectra of 1H (200 MHz) and 13C 
(50 MHz) were recorded on a Varian Mercury 200 MHz 
Spectrometer in DMSO-d6 with TMS as the internal 
standard. The chemical shifts were expressed as δ values 
in parts per million (ppm) and the coupling constants (J) 
were given in hertz (Hz). Electrospray ionization mass 
spectra were obtained with an ion trap equipment (ESI-
MS, Thermo Scientific, LTQ XL, USA), and the peak 
intensities were presented next to the corresponding m/z 
value, as a percentage relative to the height of the base 
peak. Chemical ionization mass spectra were obtained 
with a Varian Titan 4000 ion trap GC-MS.
Synthesis of hydroxychalcones using BF3•OEt2
A solution of acetophenone 1 (1.2 g, 10 mmol) 
and benzaldehyde 2 (1.1 g, 10 mmol) was prepared, kept 
stirred for 10 min, and BF3•OEt2 (0.6 mL, 2.5 mmol) 
was gradually added at room temperature. Dry dioxane 
(3-4 mL) was used as solvent. The solution was stirred for 
120 min at room temperature, subsequently washed with 
acidified water (2 x 50 mL), and the organic phase was 
extracted with ethyl acetate. The organic phase obtained 
was dried over anhydrous Na2SO4 and concentrated under 
reduced pressure. The chosen chalcone was purified from 
the crude mixture by silica gel column chromatography.
The chalcones 3c, 3i, 3k, 3l, and 3m were prepared 
according to a published general procedure (Liu, Wilairat, 
Go, 2001; Montes-Avila et al., 2009).
(E)-3-(4-hydroxyphenyl)-1-phenylprop-2-en-1-
one (3a) (Karki et al., 2010). Obtained as a yellow solid 
compound (1.07 g, 4.77 mmol); yield = 58%; mp 106-108 
°C; 1H NMR (200 MHz, DMSO-d6) δ 10.2 (br, 1H), 8.14 
(d, J = 8.2 Hz, 2H), 7.78-7.57 (m, 7H,), 6.87 (d, J = 8.8 Hz, 
2H) ppm; 13C NMR (50 MHz, DMSO-d6) δ 189.0, 160.1, 
144.5, 137.9, 132.8, 131.0, 128.7, 128.3, 125.7, 118.4, 
115.8 ppm; IR (FTIR-ATR) ν 3161, 3017, 1648, 1579, 
1283, 1157 cm-1; GC-MS m/z 225 [M+H]+.
(E)-3-(3-hydroxyphenyl)-1-phenylprop-2-en-1-
one (3b) (Karki et al., 2010). Obtained as a yellow solid 
compound (0.493 g, 2.22 mmol); yield = 32%; mp 83-85 
°C; 1H NMR (200 MHz, DMSO-d6) δ 10.4 (br, 1H), 8.08 
(d, J = 8.4 Hz, 2H), 7.97-7.64 (m, 5H), 7.46-7.43 (m, 
2H), 6.90 (d, J = 8.0 Hz, 2H) ppm; 13C NMR (50 MHz, 
DMSO-d6) δ 187.1, 162.3, 142.8, 134.9, 131.3, 130.8, 
129.1, 128.9, 128.7, 128.5, 122.1, 115.4, 115.2 ppm; IR 
(FTIR-ATR) ν 3298, 3070, 1654, 1568, 1214, 1164 cm-1; 
GC-MS m/z 225 [M+H]+.
(E)-3-(2-hydroxyphenyl)-1-phenylprop-2-en-1-one 
(3c) (Karki et al., 2010). Obtained as a greenish yellow 
solid compound (1.19 g, 5.3 mmol); yield = 80%; mp 149-
151 °C; 1H NMR (200 MHz, DMSO-d6) δ 10.3 (br, 1H), 
8.12-8.03 (m, 3H), 7.90-7.82 (m, 2H), 7.67-7.53 (m, 3H), 
7.32-7.24 (m, 1H), 6.94 (d, J = 8.4 Hz, 1H), 6.86 (d, J = 
7.4 Hz, 1H) ppm; 13C NMR (50 MHz, DMSO-d6) δ 189.4, 
157.2, 139.5, 137.8, 132.9, 132.0, 128.7, 128.3, 121.2, 
120.8, 119.3, 116.1 ppm; IR (FTIR-ATR) ν 3204, 3082, 
1638, 1560, 1228, 1150 cm-1; GC-MS m/z 225 [M+H]+.
(E)-1-(4-hydroxyphenyl)-3-phenylprop-2-en-1-one 
(3d) (Karki et al., 2010). Obtained as a pale yellow solid 
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compound (0.52 g, 2.3 mmol); yield 33%; mp 166-168 °C; 
1H NMR (200 MHz, DMSO-d6) δ 10.4 (br, 1H), 8.09 (d, 
J = 8.6 Hz, 2H), 7.97-7.81 (m, 3H), 7.68 (d, J = 15.6 Hz, 
1H), 7.47-7.43 (m, 3H), 6.91 (d, J = 8.6 Hz, 2H) ppm; 13C 
NMR (50 MHz, DMSO-d6) δ 187.1, 162.2, 142.8, 134.9, 
131.2, 130.4, 129.1, 128.9, 128.7, 122.1, 115.4 ppm; IR 
(FTIR-ATR) ν 3117, 3066, 1642, 1562, 1215, 1165 cm-1; 
GC-MS m/z 225 [M+H]+.
(E)-1,3-bis(4-hydroxyphenyl)prop-2-en-1-one (3e) 
(Karki et al., 2012). Obtained as a yellow solid compound 
(0.89 g, 3.7 mmol); yield = 47%; mp 164-166 °C; 1H NMR 
(200 MHz, DMSO-d6) δ 8.04 (d, J = 8.8 Hz, 2H), 7.84-
7.59 (m, 4H), 6.89 (d, J = 8.6 Hz, 2H), 6.83 (d, J = 8.8, 
2H) ppm; 13C NMR (50 MHz, DMSO-d6) δ 187.5, 162.4, 
160.3, 143.6, 131.4, 131.2, 129.9, 126.4, 119.0, 116.2, 
115.8 ppm; IR (FTIR-ATR) ν 3286, 3160, 1642, 1575, 
1212, 1157 cm-1; GC-MS m/z 241 [M+H]+.
(E)-1-(3-hydroxyphenyl)-3-(4-hydroxyphenyl)prop-
2-en-1-one (3f) (Karki et al., 2012). Obtained as a yellow 
solid compound (1.46 g, 6.1 mmol); yield = 71%; mp 195-
197 °C; 1H NMR (200 MHz, DMSO-d6) δ 10.1 (br, 1H), 
9.98 (br, 1H), 7.75-7.57 (m, 5H), 7.44-7.31 (m, 2H), 7.06-
7.01 (dd, J1 = 7.6, J2 = 2.4 Hz, 1H), 6.83 (d, J = 8.6 Hz, 
2H) ppm; 13C NMR (50 MHz, DMSO-d6) δ 188.9, 160.1, 
157.7, 144.4, 139.4, 131.0, 129.8, 125.8, 120.0, 119.4, 
118.6, 115.8, 114.5; IR (FTIR-ATR) ν 3335, 3285, 3076, 
1648, 1556, 1233, 1167 cm-1; ESI-MS m/z 239 [M-H]+.
(E)-3-(3,4-dihydroxyphenyl)-1-phenylprop-2-en-
1-one (3g) (Kim et al., 2008). Obtained as a yellow solid 
compound (0.26 g, 1.1 mmol); yield = 21%; mp 192-193 
°C; 1H NMR (200 MHz, DMSO-d6) δ 9.50 (br, 2H), 8.10 
(d, J = 8.0 Hz, 2H), 7.65-7.51 (m, 5H), 7.27-7.16 (m, 
2H), 6.81 (d, J = 8.0 Hz, 1H) ppm; 13C NMR (50 MHz, 
DMSO-d6) δ 189.6, 149.4, 146.2, 145.6, 138.7, 133.4, 
129.4, 128.9, 126.9, 122.9, 119.0, 116.4, 116.2 ppm; IR 
(FTIR-ATR) ν 3478, 3296, 3054, 1644, 1559, 1276, 1167 
cm-1; GC-MS m/z 297 [M+C4H9]+.
(E)-3-(3,4-dihydroxyphenyl)-1-(4-hydroxyphenyl)
prop-2-en-1-one (3h) (Kim et al., 2008). Obtained as a 
yellow solid compound (0.192 g, 0.8 mmol); yield = 18%; 
mp 190-192 °C; 1H NMR (200 MHz, DMSO-d6) δ 10.3 (br, 
1H), 9.69 (br, 1H), 9.11 (br, 1H), 8.02 (d, J = 8.8 Hz, 2H), 
7.56 (dd, J1 = 15.4, J2 = 15.6 Hz, 2H), 7.24-7.13 (m, 2H), 
6.88 (d, J = 8.8 Hz, 2H), 6.80 (d, J = 8.0 Hz, 1H) ppm; 13C 
NMR (50 MHz, DMSO-d6) δ 187.0, 161.9, 148.4, 145.5, 
143.6, 130.9, 129.5, 126.4, 121.8, 118.3, 115.6, 115.7, 
115.2 ppm; IR (FTIR-ATR) ν 3387, 3131, 3037, 1641, 
1598, 1271, 1160 cm-1; ESI-MS m/z 255 [M-H]+.
2-phenylchroman-4-one (3i). Obtained as a pale 
yellow solid compound (1.54 g, 6.9 mmol); yield = 63%; 
mp 66-68 °C; 1H NMR (200 MHz, DMSO-d6) δ 7.80 (dd, 
J1 = 7.8, J2 = 1.6 Hz, 1H), 7.65-7.41 (m, 6H), 7.13-7.07 
(m, 2H), 5.68 (dd, J1 = 13, J2 = 2.8 Hz, 1H), 3.27 (m, 1H), 
2.83 (dd, J1 = 16.8, J2 = 3.0 Hz, 1H); 13C NMR (50 MHz, 
DMSO-d6) δ 191.6, 161.0, 138.8, 136.2, 128.5, 126.6, 
126.3, 121.4, 120.6, 118.0, 78.7, 43.4; IR (FTIR-ATR) 
ν 3036, 2896, 1685, 1602, 1223, 1149 cm-1; GC-MS m/z 
225 [M+H]+.
(E)-1-phenyl-3-(4-(tetrahydro-2H-pyran-2-yloxy)
phenyl)prop-2-en-1-one (3j) (Liu et al., 2001). Obtained 
as a pale yellow solid compound (2.59 g, 8.3 mmol); 
yield = 84%; mp 76 °C; 1H NMR (200 MHz, DMSO-d6) 
δ 8.14 (d, J = 7.0, 2H), 7.86-7.53 (m, 7H), 7.08 (d, J = 
8.6 Hz, 2H), 5.58 (s, 1H), 3.79-3.53 (m, 1H), 1.87-1.56 
(m, 7H); 13C NMR (50 MHz, DMSO-d6) δ 189.9, 158.5, 
143.9, 137.7, 132.9, 130.6, 128.7, 128.3, 119.8, 116.5, 
95.4, 61.5, 29.6, 24.5, 18.4; IR (FTIR-ATR) ν 3063, 2942, 
2873, 2846, 1652, 1592, 1566, 1212, 1172 cm-1; GC-MS 
m/z 225 [M-C5H8O]+.
(E)-3-(4-nitrophenyl)-1-phenylprop-2-en-1-one (3k) 
(Montes-Avila et al., 2009). Pale brown solid (1.11 g, 4.40 
mmol); yield = 88%; mp 155-157 °C; 1H NMR (200 MHz, 
CDCl3) δ 8.28 (d, J = 8.8 Hz, 2H), 8.04 (m, 2H), 7.83 (d, 
J = 15.8 Hz, 1H), 7.79 (d, J = 8.8 Hz, 2H), 7.71-7.48 (m, 
4H); 13C NMR (50 MHz, CDCl3) δ 189.6, 141.5, 141.0, 
137.5, 133.4, 128.9, 128.8, 128.6, 125.7, 124.2; IR (FTIR-
ATR) ν 3067, 2928, 1658, 1599,1515 cm-1; ESI-MS m/z 
254 [M+H]+.
(E)-3-(4-methoxyphenyl)-1-phenylprop-2-en-1-one 
(3l) (Montes-Avila et al., 2009). Pale yellow solid (1.07 
g, 4.49 mmol); yield = 90%; mp 70-73 °C; 1H NMR (200 
MHz, CDCl3) δ 8.00 (dd, J1 = 8.3 Hz, J2 = 1.8, 2H), 7.80 
(d, J = 15.6 Hz, 1H), 7.60 (d, J = 8.8 Hz, 2H), 7.55-7.48 
(m, 3H), 7.41 (d, J = 15.6 Hz, 1H), 6.93 (d, J = 8.8 Hz, 
2H), 3.84 (s, 3H); 13C NMR (50 MHz, CDCl3) δ 190.6, 
161.7, 144.7, 138.5, 132.6, 130.2, 130.2, 128.6, 128.4, 
127.6, 119.8, 55.4; IR (FTIR-ATR) ν 3055, 2932, 1656, 
1598, 1262 cm-1; ESI-MS m/z 239 [M+H]+.
(E)-3-(4-methylphenyl)-1-phenylprop-2-en-1-one 
(3m) (Montes-Avila et al., 2009). Pale yellow solid (0.755 
g, 6.79 mmol); yield = 68%; mp 95-97 °C; 1H NMR (200 
MHz, CDCl3) δ 8.02 (d, J = 8.1 Hz, 2H), 7.80 (d, J = 15.7 
Hz, 1H), 7.60-7.44 (m, 6H), 7.22 (d, J = 8.1 Hz, 2H), 2.40 
(s, 3H); 13C NMR (50 MHz, CDCl3) δ 190.6, 145.0, 141.1, 
138.3, 132. 7, 132.1, 129.7, 128.6, 128.5, 128.4, 121.1, 
21.5; IR (FTIR-ATR) ν 3051, 2916, 1655, 1597 cm-1; 
ESI-MS m/z 223 [M+H]+.
Biological assays
H. nana adult worms
Fecal samples of humans infected with H. nana 
J. T. Díaz-Carrillo, S. P. Díaz-Camacho, F. Delgado-Vargas, I. A. Rivero, G. López-Angulo, J. I. Sarmiento-Sánchez, J. Montes-Avila
Braz. J. Pharm. Sci. 2018;54(3):e17343Page 4/13
were obtained, and the eggs of H. nana were concentrated 
by a modification of the coproparasitoscopic method 
of Sheather (Zajac et al., 2012). Sheather solution was 
prepared by dissolving 300 g of sugar in 340 mL of 
distilled water, and its density was adjusted to 1.20 g/
mL. Fecal material was rinsed twice in tap water by 
centrifugation for 5 min at 2500 rpm. The sediment was 
mixed with Sheather solution (1:9 w/v), homogenized, 
and centrifuged for 5 min at 1500 rpm. The eggs were 
collected from the surface film and their viability checked 
by Evan’s blue dye exclusion method. Three groups of 
10 BALB/c mice 5-8 weeks old were used. Each mouse 
was fed 500, 1000 or 2000 viable eggs suspended in 
100 μL of phosphate-buffered saline. At 15-21 days 
post-infection, one fecal sample from each mouse was 
examined on three consecutive days, using the methods 
of Faust and Ritchie (Faust et al., 1938; Ritchie, 1948). 
The appearance of eggs in fecal material indicated the 
presence of adult worms in the small intestine of infected 
mice. Infection efficiency varied from 60 to 80%. A dose 
of 600-1000 eggs was used to maintain the human isolate 
of H. nana in mice, as well as to obtain adult parasites 
for the antiparasitary in vitro assay. The adult parasites 
were recovered from the small intestine, washed thrice 
in phosphate buffered saline (PBS, 0.03 M, pH 7.4), and 
incubated in Hank’s medium mixed with 0.5% peptone 
and 0.2% antibiotic-antimycotic solution (penicillin G, 
streptomycin sulfate and amphotericin B). To determine 
viability and morphological changes of H. nana, the 
worms were immersed for 5 min in a 0.4% Evan’s blue 
solution, washed three times in PBS, and observed with 
a stereoscopic microscope. Dead parasites were stained 
with blue violet color, whereas live parasites remained 
unstained. The parasites in the negative control remained 
viable and with normal structures for at least 72 h.
In vitro determination of antiparasitic activity of 
hydroxychalcones
Antiparasitary evaluations were made at one 
concentration that corresponds to the praziquantel 
solubility (20 mg/mL) in Hank’s medium. Hymenolepis 
nana worms were exposed to hydroxyl chalcones or 
Praziquantel (positive control) in 24-well sterile plates, 
5 worms/well in 1 mL of medium. Parasites in Hank’s 
medium were used as negative control. The plates were 
monitored by light microscope for every hour up to 12 
h and then every 24 h up to 72 h; morphology, mobility 
and vitality were registered (Montes-Avila et al., 2017). 
Concentration-response assays of selected chalcones (1, 
5, 10, 15 and 20 mg/mL) on the antiparasitic activity were 
performed. The chosen chalcones were those that killed the 
Hymenolepis in the shortest time and caused less toxicity 
to Artemia salina.
Toxicity assays, brine shrimp lethality and the Lorke´s 
method
Brine shrimp eggs (Artemia salina) were hatched 
in artificial seawater prepared with 38 g/L of sea salt 
(Instant Ocean®, Blacksburg, VA, USA) and oxygenated 
with an aquarium pump. After incubation for 48 h at room 
temperature, nauplii were attracted to one side of the vessel 
with a light source (white neon, 70 Watt) and collected 
with a micropipette. Crustaceans were transferred to a 
96-well microplate (10-15 larvae or nauplii/100 μL), 
and compounds at different concentrations (500, 375, 
250, 125, 50 μg/mL) were added in 100 μL of seawater. 
The plates were incubated for 24 h under artificial light, 
examined with a stereoscopic microscope, and the number 
of dead nauplii per well was counted. The nauplii were 
considered dead if they were immobile for at least 10 s 
(Fernández et al., 2009). Then, 100 μL of formalin (10%) 
per well was added and the total number of shrimp was 
counted. The median lethal dose (LD50) was calculated 
with Minitab(Minitab 2000).
The acute toxicity of the chalcones with the highest 
antiparasitic activities was measured by the method 
reported by Lorke in 1983. The experiment was carried 
out with Balb/C mice in two phases. The assayed doses 
were 10, 100 and 1000 mg/kg of body weight in the first 
phase (three mice/dose); if toxicity was not achieved then 
1600, 2900 and 5000 mg/kg were assayed in the second 
phase (1 mice/dose). Treatments were given by intragastric 
administration. The mortality and general behavior of mice 
were registered for 24 h, and the LD50 was calculated as the 
geometric media  , where X1 and X2 were the 
doses at which the mice were alive and death, respectively.
In vitro evaluation of the antioxidant activity
DPPH radical scavenging assay
The radical scavenging activity was estimated 
according to the method described in literature with minor 
modifications (Sivakumar, Prabhakar, Doble, 2011). The 
DPPH radical was dissolved in ethanol (0.1 mM). An 
aliquot of the solution (1.95 mL) was mixed with 50 μL 
of each ethanol sample solution (50 μg/mL). Caffeic acid 
was used as a positive control. The reaction was stored at 
room temperature for 20 min and readings were performed 
at 517 nm in a spectrophotometer. The results were 
expressed as % of the radical disappearance (% Inhibition) 
considering control absorbance (abs control) and sample 
absorbance (abs sample):
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ABTS/persulfate assay
ABTS assay was carried out according to the method 
described previously in literature with minor modifications 
(Dueñas et al., 2010). The ABTS•+ radical was generated 
by combining 14 mM ABTS with 4.9 mM potassium 
persulfate (1:1 v/v), the mixture was allowed to stand for 
16-24 h at room temperature and darkness. The radical 
ABTS•+ was diluted with phosphate buffered saline (PBS, 
0.03 M, pH 7.4) to obtain absorbance values of 1.0 to 1.2 
at 734 nm.
For the determination of the antioxidant activity, 
50 μL of the tested compound was mixed with 1.95 mL 
of the ABTS•+ (50 μg/mL final concentration), allowed 
to stand for 10 min at room temperature in darkness, and 
readings were carried out at 734 nm. Caffeic acid was 
used as a positive control. The absorbance of the control 
was obtained by mixing 50 μL of ethanol and 1.95 mL of 
diluted ABTS•+. The results were expressed as μmol of 
Trolox equivalents/μmol of compound.
The Ferric Reducing Antioxidant Power (FRAP) assay
The ferric-reducing antioxidant power of the 
hydroxychalcones was determined by methodologies 
described in the literature with minor modifications 
(Zhang et al., 2010). The FRAP reagent was prepared 
by mixing 10 mM TPTZ solution (2.5 mL) with 40 mM 
HCl, 20 mM FeCl3 (2.5 mL) and 0.3 M acetate buffer (pH 
3.6, 25 mL). Freshly prepared FRAP reagent (1.95 mL) 
was mixed with the test compound (50 μL) or ethanol (as 
blank). The mixture was incubated for 5 min at 25 °C and 
the absorbance was measured at 593 nm. The results were 
expressed as μmol Trolox equivalents/μmol of compound.
RESULTS AND DISCUSSION
Chemistry
The appropriate acetophenone and benzaldehyde 
were condensed following published procedures (Karki 
et al., 2010; Montes-Avila et al., 2009; Narender, Reddy, 
2007) to obtain the hydroxychalcones 3a-m (Figure 1 and 
Table I).
In general, chalcone synthesis catalyzed with 
BF3•OEt2 was successful because they were obtained 
in moderate yields (Table I), and purification was easy. 
According to the literature, the aldol condensation under 
basic conditions is difficult when the aromatic aldehyde 
reagent shows an hydroxyl substituent, because the basic 
catalysts decrease the reactivity of the aldehyde by the 
relocation of the anion (Patil, Mahajan, Katti, 2009).
The synthetic chalcones were yellow solids with 
characteristic mass spectra peaks, which included the peak 
for the molecular ion. The infrared spectra signals (cm-1) of 
chalcones were assigned as follows: 3000-3200 phenolic 
hydroxyl (-OH); 1640-1690 double bonds of the α,β-
unsaturated carbonyl bond (C=O); 1590-1600 aromatic 
rings; and finally 1150-1190 for the C-O single bond.
The proton NMR data of chalcones showed 
the signals of the following groups: hydroxyl, δH 
9.0–10; aromatic rings, δH 7.0–8.0; and finally the α 
and β unsaturated system, δH 7.0–7.5. Chalcones were 
geometrically pure with trans configuration (J Hα-Hβ = 
15.5–16.0 Hz), the latter confirmed that the condensation 
reaction took place. All 1H and 13C NMR spectra signals 
agreed with the chalcone structure, which was confirmed 
by comparison to literature data (Karki et al., 2010; Karki 
et al., 2012; Kim et al., 2008).
Biology
Antiparasitic activity of hydroxychalcones
The antiparasitic activity of compounds 3a-m was 
evaluated in vitro against adult H. nana worms (Table II). 
At least one meta or para hydroxyl group in ring B was 
essential for the cestocidal activity. Evaluated at 20 mg/
mL, synthetic compounds 3a-b and 3e exhibited better 
antiparasitary activities than praziquantel (positive 
control).
Compared with the anti-H. nana activity of 
praziquantel, the activities of chalcone 3b, showing one 
meta hydroxyl group in ring B, and 3a were 6-fold and 
FIGURE 1 - Synthetic chalcones prepared with BF3•OEt2.
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TABLE I - Reaction time, yield, and melting point (mp) of the prepared chalcones
Chalcone Structure Time (min) Yield (%)a mp (°C)
3a
 
120 58 106-107
3b
 
120 32 83-84
3c
 
30 80 149-150
3d
 
120 33 166-167
3e
 
120 47 164-165
3f
 
1200 71 195-196
3g
 
2700 21 192-193
3h
 
1080 18 190-191
3i
 
1320 63 66-68
3j
 
1140 84 76
3k
 
720 88 155-157
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2-fold higher, respectively, whereas chalcone 3c was 
inactive. Moreover, 3i structure did not have hydroxyl 
groups, and the time taken for H. nana to die with 3i was 
about 200 times higher than the time taken with 3b and 3e. 
The inactive 3d compound gained anthelminthic activity 
after the introduction of an -OH group in ring B (3e), 3e 
showed higher activity than 3a. Considering the dihydroxy 
compounds 3g and 3h, they paralyzed H. nana in short 
times but induced higher times taken for the parasite 
to die (40 and 45 min, respectively) than praziquantel 
(30 min) (Table II). In addition, 3j-m chalcones lacked of 
hydroxyl groups and of antiparasitic activity (Table II). 
Thus, hydroxyl groups in chalcones were important for 
their activity against H. nana, and that in the ring B of 
our chalcones was the pharmacophore. In this respect, 
weak anthelmintic chalcones increase their activity by 
the addition of a hydroxyl group at the ortho position of 
ring A. Differences in the number, type, and position of 
substituent groups of chalcones modify their antiparasitic 
activities. Imidazopyridinyl chalcones with a meta alkyl 
group in ring B show two times higher activity against 
the nematode Haemonchus contortus than those with 
the group in ortho or para (Sissouma et al., 2011). The 
replacement of a strongly by a weakly electron donating 
TABLE I - Reaction time, yield, and melting point (mp) of the prepared chalcones (cont.)
Chalcone Structure Time (min) Yield (%)a mp (°C)
3l
 
720 90 70-73
3m
 
720 68 95-97
aYields refer to isolated products
TABLE II - Effect of the treatment of adult H. nana parasites with 20 mg/mL of chalcones1
Chalcone
Substitution pattern Time
R’ R Paralysis (seconds) Death (minutes)
3a H 4-OH 60 10
3b H 3-OH 10 5
3c H 2-OH N/D N/D
3d 4-OH H N/D N/D
3e 4-OH 4-OH 10 5
3f 3-OH 4-OH 1800 60
3g H 3,4-OH 60 40
3h 4-OH 3,4-OH 300 45
3i 900 960
3j 1800 N/D
3k H 4-NO2 N/D N/D
3l H 4-OCH3 N/D N/D
3m H 4-CH3 N/D N/D
Praziquantel - - 1200 30
Control (-) - - N/D N/D
1 R’ and R are the substituent groups as indicated in Figure. N/D indicates that parasites were still moving or alive up to 16 h of 
treatment.
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group (e.g., hydroxyl and methoxyl group, respectively) 
in the chalcone molecule increases its nematicidal activity 
from LC100= 424 μg/mL (LC100 means absolute lethal 
concentration) to LC100= 2.87 μg/mL (Sissouma et al., 
2011). On the other hand, ten synthetic chalcones were 
evaluated in vitro at concentrations of 3 to 1000 μM 
against the intracellular protozoa Leishmania braziliensis 
and Trypanosoma cruzi. Chalcone trypanocidal activity 
decreased by incorporating a chlorine atom in position para 
to both rings unlike the unsubstituted chalcone (Lunardi 
et al., 2003); based on these observations, authors report 
that the electronic effect of the para substituents in ring 
A of chalcones is not crucial for displaying antiprotozoal 
activity. Moreover, the in vitro antiplasmodial activity of 
chalcones depends on the type of ring substituents in ring 
B (alkoxy, methoxy, hydroxyl, and fluorine), but also the 
ring A substituents modify the activity (Go et al., 2004). 
The mode of action of chalcones against H. nana 
is so far unknown; however, mitochondria have been 
proposed as antiparasitic drug targets, and specifically 
by the inhibitory effect of chalcones on enzymes of the 
respiratory chain (Brophy et al., 1989; Monzote, Gille, 
2010). In this respect, several reports have demonstrated 
the antifilarial activity of chalcones against Setaria 
cervi, targeting the glutathione-S-transferase (GST); 
this enzyme is significantly inhibited by chalcones 
with chlorine and methoxy substituents (Awasthi et al., 
2009). Additionally, scientific evidence supports the 
importance of ring B substituents in the chalcones for their 
antiparasitary activities; chalcones inhibit mitochondrial 
Leishmania enzymes such as fumarate reductase, 
succinate dehydrogenase, NADH dehydrogenase, and 
NADH-cytochrome c reductase (Chen et al., 2001). It 
has been proposed that chalcones react with essential 
thiol groups of the target enzymes via Michael addition to 
the ketovinyl double bond, and enzymes are inactivated. 
Considering this mechanism, the electronic effect of the 
substituent in ring B is of great importance. Electron 
donating substituent groups (e.g., hydroxyl, methoxyl) will 
favor the antiparasitic activity because the electrophilicity 
of C-β will be increased, and the nucleophilic attack to the 
thiol groups in the enzyme will be facilitated (Aponte et 
al., 2008). 
Hymenolepis nana worms treated with 3e registered 
paralysis and rigidity at 5 min. The death of the parasite 
was evidenced with a vital staining, where the tegument 
of H. nana parasites treated with 3e and praziquantel 
was blue but did not show visible structural alterations 
under light microscopy; in contrast untreated parasites 
remained unstained. It has been suggested that chalcone 
(E)-1-(2,6-dihydroxy-4-methoxyphenyl)-3-phenylprop-
2-en-1-one alters the membrane structure of Leishmania 
amazonensis (Torres-Santos et al., 2009). Due to the 
chalcones induced short times of paralysis on H. nana; 
the mechanism of action could share similarities to that 
of Praziquantel, which increases the permeability of the 
cell membrane and the loss of intracellular calcium, and 
consequently, parasites show contractions and muscle 
paralysis (Chai, 2013; King, Mahmoud, 1989). In fact, the 
active component (2´,6´-dihidroxy-4´-methoxychalcone) 
of the methanol extract of Psidium sartorianum induces 
severe damage to the tegument and basement membrane 
of H. nana (Montes-Avila et al., 2017).
The effects of praziquantel in various trematodes 
(i.e., Clonorchis sinensis, Opisthorchis viverrini, 
Schistosoma japonicum, Metagonimus yokogawai, and 
Paragonimus westermani) has been assessed. Treatment 
with praziquantel (1 μg/mL) of C. sinensis, S. japonicum, 
and O. viverrini generates vacuolization at 5 min and more 
severe damage at longer times. Paragonimus westermani 
is the least sensitive to praziquantel, which shows less 
vacuolization at 100 μg/mL (Mehlhorn et al., 1983). The 
effect of treatment with 0.1-100 μg/mL of praziquantel 
on cestodes (i.e., Hymenolepis diminuta, Hymenolepis 
microstoma, Hymenolepis nana, and Echinococcus 
multilocularis) is similar to that described for trematodes 
(Becker et al., 1981). 
Considering the results of the brine shrimp lethality 
bioassay, compound 3b was toxic (LD50 of 255 μg/mL) 
but not 3e (LD50 > 500 μg/mL). Toxicity of phenolic 
compounds has been related with the formation of 
electrophilic metabolites that affect DNA and enzymes 
(Kumar et al., 2014). In particular, several chalcones 
inhibit the tubulin synthesis that affect the microtubule 
formation and parasite mobility, mode of action suggested 
for albendazole (Ducki, 2009; King, Mahmoud, 1989). On 
the other hand, the acute toxicity assay of Lorke showed 
that our synthetic chalcones 3b and 3e were nontoxic 
(LD50 > 5000 mg/kg). Moreover, thirty days after dose 
administration, mice did not show damage in internal 
organs (i.e. heart, thymus, lungs, spleen, liver, stomach, 
and small and large intestine).
Chalcones 3b and 3e were chosen for their killing 
effect on H. nana and for their low toxicity. Both 
compounds showed concentration-response effects related 
to the times required to paralyze and to kill H. nana (Table 
III). Compared with the activity of 3e against H. nana, the 
activity of 3b was higher, registering lower times to reach 
the paralysis and the same time to kill the parasite, both 
evaluated at 15 mg/mL. Imidazopyridinyl chalcones are 
anthelmintic against Peritima posthuma with times taken 
for such parasite to die of less than 100 min at 1 mg/mL 
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(Lakshmi, Rama-Rao, Basaveswararao, 2014). Several 
3-(3-arylpropenoyl)imidazopyridine derivatives are active 
against Haemonchus contortus, the nematicidal effect 
evaluated at 0.0005 and 0.002 μg/mL is similar to those 
registered for fenbendazole and ivermectin, and activity 
of these compounds is lost when an alkyl group is attached 
to the phenyl ring (Sissouma et al., 2011). In addition, 
chalcones 3b and 3e comply with the Lipinski Rules, 
suggesting their oral bioavailability (Lipinski et al., 2001). 
Antioxidant activity
In the DPPH assay, chalcones with two hydroxyl 
groups showed greater antioxidant activity (3e-3h), 
from which 3g and 3h with meta hydroxyl group in ring 
B were the best compounds (91 and 90% of inhibition, 
respectively). The antioxidant activities as µmol TE/µmol 
compound of 3g and 3h also showed to be the highest by 
the methods ABTS (33 and 35, respectively) and FRAP 
(2.4 and 2.7, respectively). Moreover, the activities of 
3g, 3h, and caffeic acid (positive control) were similar 
(Table IV). The facility to transfer the hydrogen atoms 
of chalcones has shown a positive association with 
their DPPH scavenging activity (Sivakumar, Prabhakar, 
Doble, 2011). As known, the chalcone hydroxyl groups 
are important for trapping radicals; and their antiradical 
activity is influenced by the number, substitution pattern, 
hydrophobicity, and polarity of the molecules (Kim 
et al., 2008; Todorova et al., 2011; Wu et al., 2007). 
Hydroxylated chalcones react with radicals and are easily 
converted to stable phenoxyl radicals. Catechol systems, 
ortho-meta- or ortho-para- di-hydroxy chalcones, are 
very efficient to delocalize electrons by transformation 
to quinines (Kim et al., 2008; Todorova et al., 2011). The 
highest antioxidant values for compounds 3g and 3h were 
attributed to the presence of the 3,4-hydroxycinnamoyl 
group (catechol) in their structures, as it was for caffeic 
acid. On the other hand, para hydroxyls in both rings 
of chalcones have little effect on the DPPH antioxidant 
activity (Kim et al., 2008). Moreover, for chalcones with 
one or two hydroxyl groups in their ring B, the antioxidant 
activity decreases in the following order 3,4-di-OH >> 
4-OH >> 3-OH > 2-OH (Todorova et al., 2011), as it 
happened with the chalcones included in this research 
(Table IV). 
Treatment of hymenolepiosis with antiparasitary 
drugs could be improved by the administration of 
exogenous antioxidants. In mice infected with H. nana, 
parasite induces host intestinal eosinophilia that produces 
oxygen radicals as mechanism of defense. In fact, 
previously challenged mice show greater production of 
radicals as well as of malondialdehyde, product of the 
lipid peroxidation (Niwa, Miyazato, 1996). In rats with 
hymenolepiosis by Hymenolepis diminuta, the intestine 
of host increases the production of oxygen radicals, shows 
an impairment of the superoxide dismutase activity, and 
an increased glutathione reductase activity; in addition, it 
is increased the reduced glutathione concentration. These 
parameters are interpreted as intestines of host are not 
enough protected against the excess of  hydrogen peroxide 
(Czeczot et al., 2012; Kosik-Bogacka et al., 2011). On 
the other hand, the rat-H. diminuta model shows that H. 
diminuta increases the activities of superoxide dismutase 
and glutathione peroxidase, enzymes which protect the 
parasite of the host immunologic response (Czeczot 
TABLE III - Concentration-response effect of selected chalcones 3b and 3e against H. nana
Chalcone 
Substitution pattern1
Concentration 
(mg/mL)
Time
R’ R Paralysis (s)
Death 
(min)
3b H 3-OH
1 3,000 50
5 1,500 25
10 600 10
15 30 5
20 10 5
3e 4-OH 4-OH
1 >7,860 180
5 6,600 120
10 2,400 40
15 1,200 20
20 10 5
1 R’ and R are the substituent groups as indicated in Figure 1.
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et al., 2013; Skrzycki et al., 2011). Thus, feeding the 
parasitized host with antioxidants could improve the 
antiparasitary treatments; this has not been demonstrated 
with hymenolepiosis but with other parasitoses. In rats 
infected with Trichinella spiralis, Se supplementation 
decreases the worm burden by 63% and increases both 
the glutathione peroxidase activity and the vitamin E level 
(Gabrashanska et al., 2010). In Leishmania infected mice, 
host presented up-regulation of the receptor of advanced 
glycation end products (involved in the production 
of reactive species), increased protein carbonylation, 
decreased IFN-γ, and impaired antioxidant defenses. Mice 
treatment with the antioxidant N-acetyl cysteine improves 
the redox state and recovers the IFN-γ levels. IFN-γ is 
required to have an adequate Th1 response to control the 
parasite (Gasparotto et al., 2015).
Several in vivo studies have shown that hydroxylated 
chalcones disrupt  the mitochondrial  oxidat ive 
phosphorylation, increasing the production of reactive 
oxygen species (ROS). High levels of ROS and an 
impaired antioxidant defensive system could lead to 
cell death via apoptosis (Guzy et al., 2010). However, 
hydroxylated chalcone analogs are free radical scavengers 
in vitro, and they show antioxidant protective effect in 
a free radical-injury Alzheimer’s model in mice (Pan et 
al., 2013). 3g and 3h showed high antioxidant activity 
in vitro and future studies must demonstrate their in vivo 
antioxidant activity.
CONCLUSION
We have synthetized chalcones with high activity 
against H. nana (3a, 3b and 3e). These were better than 
the control drug Praziquantel evaluated at the same dose. 
At least one hydroxyl meta or para in ring B of chalcones 
was essential for the anti-H. nana activity, and meta 
substitution was associated with the highest activities. On 
the other hand, the meta- and para-dihydroxy substitution 
patterns in ring B of chalcones, as in 3g and 3h, were the 
best combinations for the highest antioxidant activity. 
Further studies are in progress to demonstrate the in 
vivo antiparasitary and antioxidant effect of the selected 
chalcones. Moreover, these chalcones will be used to 
design more active molecules.
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TABLE IV - Antioxidant activity of the synthesized hydroxychalcones evaluated at 50 μg/mLa
Compound
Substitution pattern DPPH ABTS FRAP
R’ R (% Inhibition) (μmol TE/μmol compound)1
3a H 4-OH 2 ± 0.001 0.32 ± 0.001 0.07 ± 0.005
3b H 3-OH 8 ± 0.006 0.30 ± 0.005 0.01 ± 0.004
3c H 2-OH 7 ± 0.001 0.32 ± 0.001 0.08 ± 0.025
3d 4-OH H 7 ± 0.004 0.31 ± 0.003 0.01 ± 0.003
3e 4-OH 4-OH 21 ± 0.001 0.34 ± 0.000 0.15 ± 0.015
3f 3-OH 4-OH 20 ± 0.011 0.34 ± 0.000 0.16 ± 0.015
3g H 3,4-OH 91 ± 0.002 33 ± 0.001 2.4 ± 0.008c
3h 4-OH 3,4-OH 90 ± 0.002 35 ± 0.003 2.7 ± 0.053c
3i 18 ± 0.005 0.04 ± 0.002 0.01 ± 0.000
3j 4 ±0.005 0.43± 0.002 0.05 ±0.020
3k H 4-NO2 4±0.005 0.01 ± 0.010 0.01 ±0.015
3l H  4-OCH3 3±0.005 0.03 ± 0.013 0±0.003
3m H 4-CH3 3±0.005 0.03 ± 0.025 0.001±0.013
Caffeic acidb 96 ± 0.006 5.5 ± 0.001 2.2 ± 0.012c
1 TE: Trolox equivalents; a Values are the mean ± SD (n=3); b Used as a positive control; cEvaluated at 0.5 μg/mL
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